Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged ≥12 years - The RECOVER study.
J Cyst Fibros
; 2023 Oct 07.
Article
en En
| MEDLINE
| ID: mdl-37806792
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
/
Guideline
/
Qualitative_research
Idioma:
En
Revista:
J Cyst Fibros
Año:
2023
Tipo del documento:
Article